Nuclear hormone receptor NR2E3 can modulate gene expression levels associated with RP through epigenetic regulation, and the molecular reset mediated by NR2E3 was shown to reduce retinal degeneration in RP mouse models [95]. The gene discussed is NR2E3; the disease is retinitis pigmentosa 1.